Drugs / DA-5210
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05098886 | Nov 2021 → Jan 2022 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT05098262 | Oct 2021 → Jan 2022 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT05108571 | Oct 2021 → Jan 2022 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT05098275 | Oct 2021 → Feb 2022 | — | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-5210 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05098886 ↗ |